• Profile
Close

Risk-reducing oophorectomy and breast cancer risk across the spectrum of familial risk

Journal of the National Cancer Institute Mar 15, 2019

Terry MB, et al. - Using a prospective cohort, researchers examined the link between risk-reducing salpingo-oophorectomy (RRSO) and breast cancer risk. The participants were 17,917 women without breast cancer at baseline (7.2% known carriers of BRCA1 or BRCA2 mutations), followed for a median duration of 10.7 years, during which diagnosis of incident breast cancer was made in 1,046 women. As a time-varying exposure RRSO was modeled, and findings revealed no link with breast cancer risk overall or by tertiles of predicted absolute risk on the basis of family history or for BRCA1 and BRCA2 mutation carriers when assessed separately. When hormone therapy use following RRSO was taken into account, no link was found. No effectiveness for RRSO for attenuating breast cancer risk was evident.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay